Back to Ameriprise Financial Inc. Ameriprise Financial Inc.

RYTMRYTM

Showing 8 of 22 quarters

Position history for Ameriprise Financial Inc.Ameriprise Financial Inc.'s holdings in Rhythm Pharmaceuticals, Inc.

Yes. Ameriprise Financial holds 401,634 shares of RYTM (Rhythm Pharmaceuticals), worth $44.6M, as of its Q2 2026 13F filing. It increased the position by 17,677 shares (+4.6%) from Q1 2026. Ameriprise Financial has held RYTM since Q2 2022, across 17 quarterly 13F filings.

Current Value

$44.6M

Current Shares

401,634

Total Value Change

+$42.4M

Total Shares Change

+359,747

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
401,634
+4.6%
$44.6M0.0%$111.03
31
2026-Q1
Increased
383,957
+47.0%
$33.4M0.0%$86.97
40
2025-Q4
Increased
261,160
+89.3%
$28M0.0%$107.04
45
2025-Q3
Decreased
137,967
-20.3%
$13.9M0.0%$100.99
0
2025-Q2
Increased
173,069
+76.1%
$10.9M0.0%$63.19
42
2025-Q1
Increased
98,281
+84.2%
$5.2M0.0%$52.97
42
2024-Q4
Increased
53,367
+27.4%
$3M0.0%$55.98
33
2024-Q3
Increased
41,887
+3.6%
$2.2M0.0%$52.39
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used